A few clicks online. No exam, no phone call, no video visit. Minutes later, a GLP-1 prescription is headed to your door. It sounds like the future of healthcare: fast, easy, convenient. But is convenience the same thing as care?

A Yale research team wanted to find out, so they built a fake patient, sent her to 49 different online GLP-1 providers, and tracked exactly what happened. What they found may change the way you think about getting these medications online and raise questions you didn't know to ask.

Join Holly and Jim as they unpack this eye-opening "secret shopper" study and use it to explore a much bigger question: when does convenience actually improve obesity care, and when does it quietly replace it? Whether you're currently taking a GLP-1, considering one, or just curious about where obesity treatment is headed, this episode will change how you evaluate any provider online or in person.

Discussed on the episode:

• The surprising percentage of online providers that approved a prescription in some cases in under five minutes
• The critical questions almost none of the 49 companies bothered to ask before prescribing a powerful medication
• Why "getting the meds" and "getting obesity care" are two very different things
• The real risks of starting a GLP-1 without a proper medical evaluation
• What compounded GLP-1s are, and why the vast majority of online prescriptions turned out to be compounded rather than brand-name
• Why your primary care doctor absolutely needs to know you're taking one of these medications (even if your online provider never asks)
• The dose-escalation practice that has Holly worried and why more medication isn't always better
• Holly and Jim's personal, unscripted stories about when convenience backfired in their own lives
• A simple framework for evaluating whether an online (or in-person) provider is actually giving you the care you deserve